Notice Title

Consent to the Distribution of New Medicines

Publication Date
26 Oct 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go4985
Title
View PDF
File Type and Size
PDF (36 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Dasatinib Dr.Reddy’s
Active Ingredient: Dasatinib (S)-propylene glycol solvate 23.2mg equivalent to 20mg dasatinib
Dosage Form: Film coated tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Aizant Drug Research Solutions Pvt Limited, Hydrerabad, India
   
Product: Dasatinib Dr.Reddy’s
Active Ingredient: Dasatinib (S)-propylene glycol solvate 58mg equivalent to 50mg dasatinib
Dosage Form: Film coated tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Aizant Drug Research Solutions Pvt Limited, Hydrerabad, India
   
Product: Dasatinib Dr.Reddy’s
Active Ingredient: Dasatinib (S)-propylene glycol solvate 81.2mg equivalent to 70mg dasatinib
Dosage Form: Film coated tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Aizant Drug Research Solutions Pvt Limited, Hydrerabad, India
   
Product: Dasatinib Dr.Reddy’s
Active Ingredient: Dasatinib (S)-propylene glycol solvate 116mg equivalent to 100mg dasatinib
Dosage Form: Film coated tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Aizant Drug Research Solutions Pvt Limited, Hydrerabad, India
   
Product: Ryeqo 40/1/0.5
Active Ingredients: Estradiol hemihydrate 1.032mg equivalent to estradiol 1.0mg
Norethisterone acetate 0.5mg
Relugolix 40mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pharmbio Pty Limited
Manufacturer: Patheon Inc, Ontario, Canada
   
Product: Zoledronic Acid SUN
Active Ingredient: Zoledronic acid monohydrate 0.0533mg/mL equivalent to zoledronic acid 0.05mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: CARSL Consulting
Manufacturer: Sun Pharmaceutical Industries Limited, Halol, India


Dated this 20th day of October 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).